In fibroblasts from patients with systemic sclerosis, TGFβ and PDGF administration activates Fra-2 expression via non-canonical ERK signaling that, in turn, increases collagen deposition in the ECM [32]. Here, TGFB1 is linked to systemic sclerosis.